Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says.Watch here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBarr (A.G.) Regulatory News (BAG)

Share Price Information for Barr (A.G.) (BAG)

Share Price is delayed by 15 minutes
Get Live Data
618.00    5.00 (0.82%)
Bid:
617.00
Ask:
619.00
Spread: 2.00 (0.324%)
Market Cap: £685.83m
BAG Live PriceLast checked at - London Stock Exchange

Intraday Barr (A.G.) Share Chart

AGM Statement

28 May 2021 07:00

RNS Number : 1049A
Barr(A.G.) PLC
28 May 2021
 

 28 May 2021

 

A.G. BARR p.l.c.AGM Statement

 

A.G. BARR p.l.c.,"the Company", which produces and markets some of the UK's leading drinks brands, is holding its Annual General Meeting today at 12pm BST at which the following comments will be made :

 

"We are pleased to announce that trading in the year to date is in line with the Board's expectations.

 

Despite lockdown restrictions being in place across much of the first quarter, Barr Soft Drinks trading has been relatively strong since the start of the new financial year. As lockdown restrictions have eased we have seen a positive impact on both our sales volume and mix, with a shift back towards 'drink now', hospitality and leisure. Our soft drinks trading momentum has been supported by encouraging new product launches - Rubicon RAW Energy in particular achieving promising initial customer listings and consumer feedback.

While the pace and extent of the reopening of the hospitality sector varies by region, our Funkin business is already beginning to see the benefits, delivering on-trade sales that provide optimism for the sector's recovery. Across the take-home channel, the strong performance of our Funkin ready to drink cocktails during 2020 is continuing, with an increase in both customer listings and new consumers enjoying Funkin cocktails at home.

Current trading is encouraging and we have clear plans to further invest in our brands, with exciting consumer engagement and marketing activity planned across the year.

Our balance sheet remains strong and we remain committed to our plan to recommence dividend payments during the current financial year. A further update in this regard will be provided in our half year trading update in early August 2021.

Whilst there remains some uncertainty in the short term as pandemic related restrictions ease, we believe we are well placed to drive the growth of the business and remain confident in the Company's prospects for the full year."

For more information, please contact:

 

A.G. BARR 0330 390 3900 Instinctif Partners  020 7457 2010/05

Roger White, Chief Executive Justine Warren

Stuart Lorimer, Finance Director Matthew Smallwood

Next trading update - Aug 2021

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
AGMDZGZKVNVGMZM
Date   Source Headline
9th Jan 20241:36 pmRNSDirector/PDMR Shareholding
14th Dec 20239:22 amRNSDirector Declaration
11th Dec 20239:47 amRNSDirector/PDMR Shareholding
17th Nov 202310:13 amRNSUpdate statement on 2023 AGM Voting Results
8th Nov 202310:45 amRNSDirector/PDMR Shareholding
3rd Nov 20233:44 pmRNSDirector/PDMR Shareholding
30th Oct 20233:10 pmRNSDirector/PDMR Shareholding
24th Oct 20237:00 amRNSAcquisition of tropical drinks brand Rio
10th Oct 20238:21 amRNSDirector/PDMR Shareholding
26th Sep 20237:00 amRNSInterim Results
11th Sep 20239:08 amRNSDirector/PDMR Shareholding
8th Aug 20232:07 pmRNSDirector/PDMR Shareholding
1st Aug 20237:00 amRNSBoard succession announcement
1st Aug 20237:00 amRNSTrading update for the 26 weeks ended 30 July 2023
10th Jul 202312:42 pmRNSDirector/PDMR Shareholding
14th Jun 20239:40 amRNSDirector/PDMR Shareholding
13th Jun 20239:24 amRNSDirector/PDMR Shareholding - Replacement
13th Jun 20238:59 amRNSDirector/PDMR Shareholding
13th Jun 20238:55 amRNSDirector/PDMR Shareholding
12th Jun 20233:59 pmRNSDirector/PDMR Shareholding
8th Jun 20231:02 pmRNSDirector/PDMR Shareholding
26th May 20231:57 pmRNSDirectorate Change
26th May 20231:55 pmRNSResult of AGM
10th May 20239:25 amRNSDirector/PDMR Shareholding
4th May 20239:22 amRNSDirector Declaration
25th Apr 20239:14 amRNSAnnual Financial Report / Notice of AGM
12th Apr 20233:31 pmRNSDirector/PDMR Shareholding
12th Apr 202311:23 amRNSDirector/PDMR Shareholding
11th Apr 202310:07 amRNSDirector/PDMR Shareholding
30th Mar 202310:24 amRNSDirector/PDMR Shareholding
28th Mar 20237:00 amRNSBoard succession update
28th Mar 20237:00 amRNSFinal results for the year ended 29 January 2023
8th Mar 202310:57 amRNSDirector/PDMR Shareholding
8th Feb 202311:09 amRNSDirector/PDMR Shareholding
31st Jan 20237:00 amRNSTrading Update
27th Jan 20232:39 pmRNSNotice of Trading Update
10th Jan 20232:01 pmRNSDirector/PDMR Shareholding
20th Dec 20227:00 amRNSAcquisition of MOMA minority shareholding
14th Dec 20226:00 pmRNSContourGlobal
8th Dec 202212:56 pmRNSDirector/PDMR Shareholding
5th Dec 20227:00 amRNSAcquisition of Boost Drinks Holdings Limited
8th Nov 202210:41 amRNSDirector/PDMR Shareholding
1st Nov 20222:38 pmRNSDirector/PDMR Shareholding
1st Nov 20222:34 pmRNSDirector/PDMR Shareholding
1st Nov 20222:30 pmRNSDirector/PDMR Shareholding
25th Oct 20229:34 amRNSDirectorship
10th Oct 20221:44 pmRNSDirector/PDMR Shareholding
27th Sep 20227:05 amRNSUpdate statement on 2022 AGM Voting Results
27th Sep 20227:00 amRNSInterim Results
12th Sep 20223:18 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.